15 /100
LOW RISK
Score updated May 29, 2026

GRCE — Grace Therapeutics, Inc. Dilution Risk Tracker

Track GRCE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GRCE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GRCE.
🔔 Track GRCE — Get forecast alerts →

💹 Market Data

Market Cap$37.60M
Shares Outstanding15.47M
Float12.79M
Cash$18.67M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 47.4% shares (2025Q4 vs prior)
22 institutional holders · 5.46M shares
#1 ADAR1 Capital Management, LLC 1.28M shares
#2 Nantahala Capital Management, LLC 1.18M shares
#3 BANK OF AMERICA CORP /DE/ 989.4K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.20M
Days to Cover1.4
% of Float17.2%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track GRCE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GRCE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GRCE
📊 GRCE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GRCE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.